Evaluation of glycemic control following discontinuation of an intensive insulin protocol
The DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Intensive insulin protocols (IIPs) have been demonstrated to reduce morbidity and mortality in critically ill patients. Currently, there are no published studies evaluating glycemic control after discontinuation of an IIP. OBJECTIVE: The purpose of this study was to compare blood glucose (BG) control during an IIP and for 5 days following its discontinuation (follow‐up period). METHODS: The study was a retrospective review of intensive care unit patients who received an IIP for ≥24 hours. Data were collected during the last 12 hours of the IIP and subsequent follow‐up period. RESULTS: For all 65 included patients, the mean ± standard deviation for BG on the IIP was 123 ± 26 mg/dL versus 168 ± 50 mg/dL following discontinuation of the IIP (P < 0.001). The median (interquartile range) insulin that was administered decreased from 40 (22–65) units on the IIP to 8 (0–18) units after the IIP was stopped (P < 0.001). The mean daily BG during the follow‐up period was significantly higher than that during the IIP (P < 0.001). Additionally, an insulin requirement of >20 units during the last 12 hours of the IIP was identified as a risk factor for poor glycemic control during the follow‐up period (odds ratio: 4.62; 95% confidence interval: 1.17–18.17). CONCLUSIONS: This study demonstrates a significant increase in BG following discontinuation of an IIP. Higher insulin requirements during the last 12 hours of an IIP were identified as an independent risk factor for poor glycemic control following the IIP. A standardized insulin transition protocol may help better control BG after discontinuation of an IIP. Journal of Hospital Medicine 2009;4:28–34. © 2009 Society of Hospital Medicine.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hyperglycemia: an independent marker of in-hospital mortality in patients with undiagnosed diabetes
Umpierrez, G. E., Isaacs, S. D., Bazargan, N., You, X., Thaler, L. M., & Kitabchi, A. E. (2002) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.87.3.8341 · Cited by 2,195
Malmberg, K., Rydén, L., Efendic, S., Herlitz, J., Nicol, P., Waldenstrom, A., Wedel, H., & Welin, L. (1995) · Journal of the American College of Cardiology · doi:10.1016/0735-1097(95)00126-k · Cited by 1,560 · cited 2×
“Patients with >200 mg/dL, n (%) 11 (17) 37 (57)* 31 (48)* 26 (41)* 33 (53)* 34 (58)* Patients with >300 mg/dL, n (%) 2 (3) 11 (17) 7 (11) 8 (12) 5 (8) 10 (17)”
Management of diabetes and hyperglycemia in hospitals.
Clement, S., Braithwaite, S. S., Magee, M. F., Ahmann, A., Smith, E. P., Schafer, R. G., Hirsch, I. B., & on behalf of the Diabetes in Hospitals Writing Committee (2004) · Diabetes Care · doi:10.2337/diacare.27.2.553 · Cited by 1,266 · cited 1×
“Patients with >200 mg/dL, n (%) 11 (17) 37 (57)* 31 (48)* 26 (41)* 33 (53)* 34 (58)* Patients with >300 mg/dL, n (%) 2 (3) 11 (17) 7 (11) 8 (12) 5 (8) 10 (17)”
McCowen, K. C., Malhotra, A., & Bistrian, B. R. (2001) · Critical Care Clinics · doi:10.1016/s0749-0704(05)70154-8 · Cited by 1,170 · cited 2×
“Patients were excluded from the study if they met any of the following criteria: (1) complete BG measurements were not retrievable while the patient received the IIP or for the 5 days following discontinuation of the IIP, (2) the patient died while receiving the IIP, and (3) an endocrinologist was involved in the care…”
BackgroundMethodMalmberg, K., Rydén, L., Wedel, H., Birkeland, K., Bootsma, A., Dickstein, K., Efendic, S., Fisher, M., Hamsten, A., Herlitz, J., et al. (2005) · European Heart Journal · doi:10.1093/eurheartj/ehi199 · Cited by 1,048
Umpierrez, G. E., Smiley, D., Zisman, A., Prieto, L. M., Palacio, A., Ceron, M., Puig, A., & Mejia, R. (2007) · Diabetes Care · doi:10.2337/dc07-0295 · Cited by 671
Cited by
Standards of medical care in diabetes—2014
American Diabetes Association (2014) · Diabetes Care · doi:10.2337/dc14-s014 · Cited by 4,572
Standards of medical care in diabetes—2013
American Diabetes Association (2013) · Diabetes Care · doi:10.2337/dc13-s011 · Cited by 4,369
“When the patient is transitioned off intravenous insulin to subcutaneous therapy, precautions should be taken to prevent hyperglycemia escape (472,473).”
BackgroundStandards of medical care in diabetes—2011
American Diabetes Association (2011) · Diabetes Care · doi:10.2337/dc11-s011 · Cited by 2,880
Standards of Medical Care in Diabetes—2012
(2012) · Diabetes Care · doi:10.2337/dc12-s011 · Cited by 2,240
Hsia, E., Seggelke, S., Gibbs, J., Hawkins, R. M., Cohlmia, E., Rasouli, N., Wang, C., Kam, I., & Draznin, B. (2012) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2012-1244 · Cited by 112
Review of evidence for adult diabetic ketoacidosis management protocols
Tran, T. T. T., Pease, A., Wood, A. J., Zajac, J. D., Mårtensson, J., Bellomo, R., & Ekinci, E. I. (2017) · Frontiers in Endocrinology · doi:10.3389/fendo.2017.00106 · Cited by 97
Lim, Y., Ohn, J. H., Jeong, J., Ryu, J., Kim, S.-W., Cho, J. H., Park, H.-S., Kim, H. W., Lee, J., Kim, E. S., et al. (2022) · Endocrinology and Metabolism · doi:10.3803/enm.2021.1341 · Cited by 14
“Although several different methods of transition from IV insulin have been described [6-9], rebound hyperglycemia remains a major challenge in practice [10,11].”
BackgroundInpatient hyperglycemia and transitions of care: A systematic review
Lansang, M. C., Zhou, K., & Korytkowski, M. T. (2021) · Endocrine Practice · doi:10.1016/j.eprac.2021.01.016 · Cited by 9
Metadata
- Authors
- Czosnowski, Q. A., Swanson, J. M., Lobo, B. L., Broyles, J. E., Deaton, P. R., & Finch, C. K.
- Venue
- Journal of Hospital Medicine
- Publisher
- Wiley
- Published
- 2009-01
- Volume
- 4
- Issue
- 1
- Pages
- 28-34
- ISSN
- 1553-5592 (ISSN-L)
- 1553-5606
- OpenAlex
- W2002421300
- Cited by
- 22
- References
- 6
- FWCI
- 2.17
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.